MF Wendel SE

WENDEL: 2020 Annual General Meeting

WENDEL: 2020 Annual General Meeting

2020 Annual General Meeting

Wendel’s Annual General Meeting will be postponed to July 2, 2020. This decision will enable Bureau Veritas’ Annual Shareholders Meeting to precede that of Wendel as has been the case every year and also to potentially preserve shareholders’ ability to participate in the meeting in person.



After a very good 2019 financial performance and in light of its solid balance sheet, Wendel had announced a €2.90 per share dividend on March 17. Wendel wants to have a better understanding of the macroeconomic and health situation prior to confirming this decision.



About Wendel

Wendel is one of Europe's leading listed investment firms. The Group invests in Europe, North America and Africa in companies which are leaders in their field, such as Bureau Veritas, Cromology, Stahl, IHS, Constantia Flexibles, Allied Universal, Crisis Prevention Institute and Tsebo. Wendel plays an active role as a controlling or lead shareholder in these companies. We implement long-term development strategies, which involve boosting growth and margins of companies so as to enhance their leading market positions.

Wendel is listed on Eurolist by Euronext Paris.

Standard & Poor’s ratings: Long-term: BBB, stable outlook – Short-term: A-2 since January 25, 2019

Moody’s ratings: Long-term: Baa2, stable outlook – Short-term: P-2 since September 5, 2018

Wendel is the Founding Sponsor of Centre Pompidou-Metz. In recognition of its long-term patronage of the arts, Wendel received the distinction of “Grand Mécène de la Culture” in 2012.

For more information: wendelgroup.com

Follow us on Twitter @WendelGroup

Attachment

EN
14/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wendel SE

Carole Braudeau
  • Carole Braudeau

Credit Morning 02/18/2026

Tereos : -57% EBITDA over 9M 25/26. Guidance reaffirmed for a leverage peak at 6x as of March 31|Celanese – still challenging conditions but margins and FCF generation remain healthy|Emeis reported 2025 results ahead of expectations|

ResearchPool Subscriptions

Get the most out of your insights

Get in touch